[Vaccines against meningococcal disease].

Area of Science:

• Microbiology
• Epidemiology
• Vaccinology

Context:

• Meningococcal disease poses a significant global health threat, with periodic epidemics reported worldwide.
• Neisseria meningitidis serogroups A, B, and C are the most prevalent and concerning.
• Existing vaccines target serogroups A, C, Y, and W-135 but have limitations in age range and duration of protection.

Purpose:

• To review the current landscape of meningococcal vaccines and chemoprophylaxis strategies.
• To highlight the challenges in developing effective vaccines, particularly against serogroup B.
• To discuss future perspectives in meningococcal disease prevention.

Summary:

• Vaccines against meningococcal serogroups A, C, Y, and W-135 are available but not routinely used due to limitations.
• No consistently effective vaccines exist for serogroup B meningococci, necessitating ongoing research.
• Chemoprophylaxis for close contacts remains the primary method to prevent secondary cases.

Impact:

• Emphasizes the need for improved meningococcal vaccines, especially for serogroup B.
• Underscores the importance of continued epidemiological surveillance for meningococcal disease.
• Suggests that conjugated vaccine technologies may offer future breakthroughs in prevention.